Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.

J Ahn, S Kim, M Ahn, J Lee, J Uhm, J Sun… - Journal of Clinical …, 2010 - ascopubs.org
7551 Background: Gefitinib and erlotinib are potent inhibitors of the epidermal growth factor
receptor tyrosine kinase (EGFR TK), with single agent antitumor activity. In this randomized …
被引用次数：8 相关文章

[引用][C] Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

J Ahn, S Kim, M Ahn, J Lee, J Uhm… - JOURNAL OF …, 2010 - scholarworks.bwise.kr
ScholarWorks@SUNGKYUNKWAN UNIVERSITY: Randomized phase II study of gefitinib
versus erlotinib in patients with advanced non-small cell lung cancer who failed previous …